Dow Jones
32 105,25 +75,14 (+0,23 %) Nasdaq
11 787,40 +117,44 (+1,01 %) Nikkei 225
27 385,25 -34,36 (-0,13 %) EUR/USD
1,0831 -0,0006 (-0,05 %) HANG SENG
19 902,16 -147,48 (-0,74 %) Bitcoin EUR
26 130,02 +545,05 (+2,13 %)
Gilead Sciences, Inc. (GILD)
Échanges après Bourse :
| Clôture précédente | 77,81 |
| Ouverture | 77,78 |
| Offre | 0,00 x 800 |
| Vente | 0,00 x 900 |
| Var. jour | 77,65 - 78,93 |
| Sur 52 semaines | 57,17 - 89,74 |
| Volume | |
| Volume moyen | 6 194 930 |
| Cap. boursière | 98,222B |
| Bêta (mensuel sur 5 ans) | 0,40 |
| Rapport P/E (sur 12 mois) | 21,82 |
| BPA (sur 12 mois) | 3,61 |
| Date de bénéfices | 26 avr. 2023 - 01 mai 2023 |
| Dividende et rendement à terme | 3,00 (3,78 %) |
| Date ex-dividende | 14 mars 2023 |
| Objectif sur 1 an | 88,96 |
- ACCESSWIRE
Gilead Sciences: A Career Rooted in Championing Diversity and Inclusion: Jesse's Story
NORHAMPTON, MA / ACCESSWIRE / November 10, 2022 / Gilead Sciences While Jesse Garcia was growing up in Chicago's inner city, his parents didn't immediately turn to a doctor when someone in the family got sick. "We relied on traditional Latino ...
- ACCESSWIRE
Gilead's Path to Equitable Global COVID-19 Treatment Access
NORTHAMPTON, MA / ACCESSWIRE / November 2, 2022 / Gilead Sciences Since the beginning of the COVID-19 pandemic, Gilead's first-in-class antiviral was made available to more than 11 million patients globally- over 65% of whom live in low-and lower-middle-income ...
- ACCESSWIRE
Gilead Sciences: Metastatic Breast Cancer Advocate Urges Black People to Join Clinical Trials
In the spring of 2018, North Carolina native Stephanie Walker went to her first breast cancer conference and had a revelation that she refers to as her "coming-out party." She learned she had metastatic breast cancer three years earlier and although she was a retired hospice nurse, she faced the disease without any guidance from others who shared her experience.
